Santhosh joined NEA as a Principal on the Healthcare Team in 2018 and primarily focuses on investments in biopharmaceuticals. Prior to joining NEA, Santhosh was a Vice President at Cowen and Company in Equity Research, where he covered SMID Cap Biotechnology stocks across all therapeutic areas. Prior to Cowen, Santhosh was an Associate Director in oncology clinical development at Pfizer. Prior to Pfizer, he was a preclinical scientist at Millennium Pharmaceuticals/Takeda.
Santhosh earned his PhD in Biomedical Engineering from the University of Pennsylvania and completed his postdoctoral work in Biochemistry and Molecular Biophysics at Columbia University. He is a CFA Charterholder.